Part 3, Reference for Chapter 28: Leprosy
Skip chapter table of contents and go to main content
- 1 Epidemiology of leprosy in Norway. The history of the National Leprosy Registry of Norway from 1856 until today. Int J Epidemiol 1973;2:81–9. Cross Ref link Pubmed link , .
- 2 Undersolgelser angraaende spedalskhedens aasger.] Norsk Magazin Laegervidens Kaben 1874;4 (Suppl.):1–88. . [
- 3 Anonymous. Leprosy: global situation 2012. Wkly Epidemiol Rec 2012;87:317–28. Pubmed link
- 4 The diagnosis of leprosy is delayed in the United Kingdom. QJM 2001;94:207–12. Cross Ref link Pubmed link , .
- 5 Mortality in leprosy. Indian J Med Res 1972;60:439–45. Pubmed link .
- 6 The epidemiology of leprosy. In: Hastings RC, ed. Leprosy. Edinburgh: Churchill Livingstone, 1994:15–30. .
- 7 Leprosy: the epidemiology of a slow bacterium. Epidemiol Rev 1982;4:161–88. Pubmed link .
- 8 Leprosy in Louisiana, 1855–1970. An epidemiologic study of long‐term trends. Am J Epidemiol 1975;102:303–10. Pubmed link , .
- 9 Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004;427:636–40. Cross Ref link Pubmed link , , , et al.
- 10 The ubiquitin proteolytic system. Neurology 2006;66(Suppl. 1):1–13. Cross Ref link Pubmed link .
- 11 Association of vitamin D receptor genotype with leprosy type. J Infect Dis 1999;179:187–91. Cross Ref link Pubmed link , , , et al.
- 12 Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 1997;176:530–2. Cross Ref link Pubmed link , , , et al.
- 13 Role of tumor necrosis factor‐alpha and interleukin‐10 promoter gene polymorphisms in leprosy. J Infect Dis 2002;186:1687–91. Cross Ref link Pubmed link , , , et al.
- 14 Large‐scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg 2004;71:330–40. Pubmed link , , , et al.
- 15 Interleukin‐10 promoter single‐nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy. Genes Immun 2004;5:592–5. Cross Ref link Pubmed link , , , et al.
- 16 IL‐10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy. Hum Genet 2005;118:295–300. Cross Ref link Pubmed link , , , et al.
- 17 Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus‐infected individuals. Infect Immun 1995;63:1848–54. Pubmed link , , , et al.
- 18 Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immuno‐deficiency virus‐infected person. Clin Infect Dis 2003;36:e5–6. Cross Ref link Pubmed link , , .
- 19 Interactions between HIV infection and leprosy: a paradox. Lancet Infect Dis 2006;6:350–60. Cross Ref link Pubmed link , , .
- 20 Clinical and histological features of leprosy and HIV co‐infection in Brazil. Br J Dermatol 2013;38:470–7. , , .
- 21 Comparison of the modes of spread and the incidence of tuberculosis and leprosy. Lancet 1974;1:47–8. Cross Ref link Pubmed link , .
- 22 Leprosy in Britain: 50 years experience in Liverpool. QJM 2005;98:505–11. Cross Ref link Pubmed link , , , et al.
- 23 Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia. Epidemiol Infect 2003;131:841–8. Cross Ref link Pubmed link , , , et al.
- 24 Transmission of leprosy in nude mice. Am J Trop Med Hyg 1985;34:1161–6. Pubmed link , , .
- 25 Pathogenesis of Leprosy and Related Diseases. London: Wright, 1988. .
- 26 Immune response to Mycobacterium leprae in indeterminate leprosy patients. Acta Pathol Microbiol Scand [B] Microbiol Immunol 1973;81:615–20. Pubmed link , , , et al.
- 27 The continuous bacteremia of lepromatous leprosy. N Engl J Med 1972;287:159–64. Cross Ref link Pubmed link , , .
- 28 Reactions in leprosy. Lepr Rev 1970;41:62–3. Pubmed link .
- 29 Cutaneous nerves in leprosy: the relationship between histopathology and cutaneous sensibility. Brain 1955;78:615–33. Cross Ref link Pubmed link .
- 30 Cardiovascular dysautonomia in patients with lepromatous leprosy. Indian J Lepr 1990;62:91–7. Pubmed link , , , et al.
- 31 Impairment of vasomotor reflexes in the fingertips of leprosy patients. J Neurol Neurosurg Psychiatry 1991;54:965–71. Cross Ref link Pubmed link , , , et al.
- 32 Clinical, electrophysiological, quantitative, histologic and ultrastructural studies of the index branch of the radial cutaneous nerve in leprosy. I. Preliminary report. Int J Lepr Other Mycobact Dis 1975;43:106–13. Pubmed link , , , .
- 33 Quantitative, histologic and ultrastructural studies of the index branch of the radial cutaneous nerve in leprosy and its correlation with electrophysiologic study. Int J Lepr Other Mycobact Dis 1975;43:256–64. Pubmed link , , , .
- 34 Study of the evolution of nerve damage in leprosy. Part I – lesions of the index branch of the radial cutaneous nerve in early leprosy. Lepr India 1980;52:5–18. Pubmed link , , , .
- 35 Leprosy – histopathologic aspects of nerve involvement. Contemp Neurol Ser 1975;12:17–28. Pubmed link , .
- 36 Classification of leprosy according to immunity. A five‐group system. Int J Lepr Other Mycobact Dis 1966;34:255–73. Pubmed link , .
- 37 Pathologic changes and their distribution in peripheral nerves in lepromatous leprosy. Int J Lepr Other Mycobact Dis 1968;36:257–70. Pubmed link , .
- 38 Pathology of peripheral nerve lesions in lepromatous leprosy – a light and electron microscopic study. Int J Lepr Other Mycobact Dis 1971;39:251–68. Pubmed link .
- 39 Mechanism of nerve destruction in tuberculoid‐borderline leprosy. An electron‐microscopic study. J Neurol Sci 1973;20:25–38. Cross Ref link Pubmed link .
- 40 The histological course of reactions in borderline leprosy and their outcome. Int J Lepr Other Mycobact Dis 1981;49:383–92. Pubmed link , .
- 41 The histological diagnosis of leprosy type 1 reactions: identification of key variables and an analysis of the process of histological diagnosis. J Clin Pathol 2008;61:595–600. Cross Ref link Pubmed link , , , et al.
- 42 Leprosy. Lancet 2004;363:1209–19. Cross Ref link Pubmed link , .
- 43 Host defense mechanisms triggered by microbial lipoproteins through Toll‐like receptors. Science 1999;285:732–3. Cross Ref link Pubmed link , , , et al.
- 44 Activation and regulation of Toll‐like receptors 2 and 1 in human leprosy. Nature Med 2003;9:525–32. Cross Ref link Pubmed link , , , et al.
- 45 Interaction of dendritic cells with mycobacteria: where the action starts. Immunol Cell Biol 2000;78:318–24. Cross Ref link Pubmed link , .
- 46 The macrophage in leprosy: a review on the current status. Int J Lepr Other Mycobact Dis 1989;57:511–25. Pubmed link , .
- 47 Cellular immune responses of leprosy contacts to fractionated Mycobacterium leprae antigens. Infect Immun 1989;57:2475–80. Pubmed link , , , et al.
- 48 In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol 1984;132:3085–90. Pubmed link , , , et al.
- 49 Antibody response to recombinant 65‐kDa, 70‐kDa and 18‐kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy‐endemic population. Int J Lepr Other Mycobact Dis 1984;62:245–55. , , , .
- 50 Multiple skin testing in leprosy. J Hyg (Lond) 1975;75:57–68. Cross Ref link Pubmed link , , .
- 51 Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci USA 1988;85:1213–17. Cross Ref link Pubmed link , , , et al.
- 52 T‐cell conditioned media reverse T‐cell unresponsiveness in lepromatous leprosy. Nature 1983;303:342–4. Cross Ref link Pubmed link , , , et al.
- 53 The reconstitution of cell‐mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2. J Exp Med 1989;169:893–907. Cross Ref link Pubmed link , , , et al.
- 54 Tumour necrosis factor‐α (TNF‐α) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin Exp Immunol 1995;99:196–202. Cross Ref link Pubmed link , , , et al.
- 55 Cytokine patterns of immunologically mediated tissue damage. J Immunol 1992;149:1470–5. Pubmed link , , , et al.
- 56 Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet 1969;2:933–5. Cross Ref link Pubmed link , , , .
- 57 Towards understanding the pathology of erythema nodosum leprosum. Trans R Soc Trop Med Hyg 2008;102:329–37. Cross Ref link Pubmed link , .
- 58 Enhanced cell‐mediated immune response in erythema nodosum leprosum reactions of leprosy. Int J Lepr Other Mycobact Dis 1987;55:36–42. Pubmed link , .
- 59 Serum levels of tumour necrosis factor‐α and interleukin‐1β during leprosy reactional states. Clin Exp Immunol 1991;84:103–8. Pubmed link , , , .
- 60 The mouse foot‐pad technique for cultivation of Mycobacterium leprae. Lepr Rev 2006;77:5–24. Pubmed link , .
- 61 Animal models in leprosy. In: Rees RJW, ed. Tuberculosis and Leprosy. British Medical Bulletin, Vol. 44. Edinburgh: Churchill Livingstone, 1988:650–64. .
- 62 The nine‐banded armadillo: a model for leprosy and other biomedical research. Int J Lepr Other Mycobact Dis 1971;39:703–14. Pubmed link .
- 63 Probable zoonotic for leprosy in the Southern United States. N Engl J Med 2011;364:1626–33 Cross Ref link Pubmed link , , .
- 64 Massive gene decay in the leprosy bacillus. Nature 2001;409:1007–11. Cross Ref link Pubmed link , , , et al.
- 65 The integrated genome map of Mycobacterium leprae. Lepr Rev 2001;72:462–9. Pubmed link , .
- 66 On the origin of leprosy. Science 2005;308(5724):1040–2. Cross Ref link Pubmed link , , , et al.
- 67 A genome‐wide comparison of medieval and modern Mycobacterium leprae. Science 2013;341:179–83. Cross Ref link Pubmed link , , .
- 68 On the age of leprosy. PLOS Negl Trop Dis 2014;Feb 8(2):e2544. Cross Ref link Pubmed link , .
- 69 Chemical definition, cloning, and expression of the major protein of the leprosy bacillus. Infect Immun 1994;62:2417–25. Pubmed link , , , et al.
- 70 Use of polymerase chain reaction to assess efficacy of leprosy chemotherapy. Lancet 1993;342:264–8. Cross Ref link Pubmed link , , , et al.
- 71 Molecular basis of rifampin resistance in Mycobacterium leprae. Antimicrob Agents Chemother 1993;37:414–18. Cross Ref link Pubmed link , .
- 72 Occurrence of leprosy in US veterans after service in endemic areas abroad. Public Health Rep 1969;84:1051–8. Cross Ref link Pubmed link , , .
- 73 Leprosy, 3rd edn. Edinburgh: Churchill Livingstone, 1990. , .
- 74 Indeterminate leprosy. A passing phase in the evolution of leprosy. Lepr Rev 1987;58:291–9. Pubmed link , .
- 75 Lepromatous leprosy presenting with polyarthritis, myositis, and immune‐complex glomerulonephritis. BMJ 1975;3:619–21. Cross Ref link Pubmed link , , , .
- 76 Leprosy in reaction: a medical emergency. BMJ 1991;302:1324–6. Cross Ref link Pubmed link , , , .
- 77 A clinical study of the nose in lepromatous leprosy. Lepr Rev 1974;45:135–44. Pubmed link .
- 78 Changes in the anterior nasal spine and the alveolar process of the macillae in leprosy: a clinical examination. Int J Lepr Other Mycobact Dis 1974;42:431–5. Pubmed link .
- 79 The ‘spotted’ leprosy of Lucio (la lepra ‘manchada’ de Lucio). An introduction to its clinical and histological study. Int J Lepr Other Mycobact Dis 1948;16:421–9. , .
- 80 The histoid variety of lepromatous leprosy. Int J Lepr Other Mycobact Dis 1963;31:129–42. .
- 81 Histological studies in primary neuritic leprosy: changes in the apparently normal skin. Lepr Rev 1998;69:351–7. Pubmed link , , , , .
- 82 A study of pure neuritic leprosy: clinical experience. Indian J Lepr 1996;68:137–41. Pubmed link , , .
- 83 Sarcoidosis of the nervous system. J Neurol Neurosurg Psychiatry 1965;28:23. Cross Ref link Pubmed link .
- 84 Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease. Trans R Soc Trop Med Hyg 1969;63:708–37. Cross Ref link Pubmed link .
- 85 Post kala‐azar dermal leishmaniasis. Br J Dermatol 1972;87:374–8. Cross Ref link Pubmed link , , .
- 86 Differential diagnosis. In: Hastings RC, ed. Leprosy. Edinburgh: Churchill Livingstone, 1994:291–313. , .
- 87 Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India. Int J Lepr Other Mycobact Dis 1993;61:8–15. Pubmed link , , , et al.
- 88 The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline. Lepr Rev 2005;76:277–95. Pubmed link , , , et al.
- 89 Clinical course of erythema nodosum leprosum: an 11‐year cohort study in Hyderabad, India. Am J Trop Med Hyg 2006;74:868–79. Pubmed link , , , et al.
- 90 Towards understanding the pathology of erythema nodosum leprosum. Trans R Soc Trop Med Hyg 2008;102:329–37. Cross Ref link Pubmed link , .
- 91 The role of thalidomide in the management of erythema nodosum leprosum. Lepr Rev 2007;78:197–215. Pubmed link , , .
- 92 Lucio's phenomenon: a comparative histological study. Int J Lepr Other Mycobact Dis 1979;47:161–6. Pubmed link , .
- 93 Nerve involvement in leprosy – pathology, differential diagnosis and principles of management. Lepr Rev 1975;46:199–212. Pubmed link , .
- 94 A study of autonomic functions in leprosy. Lepr India 1982;54:303–17. Pubmed link , .
- 95 Nerve function impairment in leprosy. Design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (the Bangladesh Acute Nerve Damage Study). Lepr Rev 1999;70:140–59. Pubmed link , , , .
- 96 The pattern of leprosy‐related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome. Lepr Rev 2000;71:285–308. Pubmed link , , , et al.
- 97 Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia. Lepr Rev 2002;73:225–38. Pubmed link , , , et al.
- 98 Progression of eye lesions in leprosy. Ten‐year follow‐up study in the Netherlands. Int J Lepr Other Mycobact Dis 1991;59:392–7. Pubmed link , .
- 99 An Atlas of Leprosy. Tokyo: Sasakawa Memorial Health Foundation, 1983. , , .
- 100 Therapeutic trials in leprosy using serial biopsies. Lepr Rev 1958;29:45–52. Pubmed link .
- 101 World Health Organization. Guidelines for slit skin smears. Int J Lepr Other Mycobact Dis 1987;55:421–2.
- 102 Skin Biopsy in Leprosy. Basel: Documenta Geigy, 1977. .
- 103 The serodiagnosis of leprosy. Lepr Rev 1992;63:97–100. Pubmed link .
- 104 The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients. Lepr Rev 2007;78:70–9. Pubmed link , , , et al.
- 105 Pregnancy and leprosy: a comprehensive literature review. Int J Lepr Other Mycobact Dis 1999;67:6–12. Pubmed link , .
- 106 Drug resistance in leprosy – a review. Lepr Rev 1985;56:265–78. Pubmed link .
- 107 World Health Organization. Chemotherapy of Leprosy for Control Programmes. Technical Report Series 675. Geneva: World Health Organization, 1982.
- 108 The bactericidal effect of rifampicin on M. leprae in man: (a) single doses of 600, 900 and 1200 mg; and (b) daily doses of 300 mg. Int J Lepr Other Mycobact Dis 1976;44:183–7. Pubmed link , , .
- 109 Rifampin‐resistant leprosy. Lancet 1976;2:1304–5. Cross Ref link Pubmed link , .
- 110 Fatal reaction to dapsone during treatment of leprosy. Ann Intern Med 1981;94:777–9. Cross Ref link Pubmed link , , , .
- 111 World Health Organization. Chemotherapy of Leprosy. Technical Report Series 847. Geneva: World Health Organization, 1994.
- 112 Leprosy. Clin Evid 2002;8:709–20. Pubmed link .
- 113 Relapses after fixed duration multiple drug therapy: the AMFES cohort. Lepr Rev 2000;71:325–31. Pubmed link , , .
- 114 Four‐year follow‐up results of a WHO‐recommended multiple‐drug regimen in paucibacillary leprosy patients in Malawi. Int J Lepr Other Mycobact Dis 1991;59:255–61. Pubmed link , , , .
- 115 A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand: a prospective study, 1984–96. Int J Lepr Other Mycobact Dis 1997;65:28–36. Pubmed link , , .
- 116 Relapse after long‐term follow up of multibacillary patients treated by WHO multidrug regimen. Marchoux Chemotherapy Study Group. Int J Lepr Other Mycobact Dis 1995;63:195–201. Pubmed link , .
- 117 Relapses in multibacillary leprosy patients: effect of length of therapy. Lepr Rev 2000;71:144–53. Pubmed link , , .
- 118 Rifampicin resistant leprosy: a review and a research proposal of a pilot study. Lepr Rev 2002;73:2–8. Pubmed link .
- 119 World Health Organization. Report of the Third Meeting of the WHO Technical Advisory Group on the Elimination of Leprosy. Geneva: WHO/CDS/CPE/CEE, 2002.
- 120 Leprosy elimination – a virtual phenomenon or a reality? BMJ 2002;324:1516–18. Cross Ref link Pubmed link .
- 121 Effectiveness of pefloxacin in the treatment of lepromatous leprosy. Int J Lepr Other Mycobact Dis 1990;58:12–18. Pubmed link , , , .
- 122 A clinical trial of minocycline in lepromatous leprosy. BMJ 1992;304:91–2. Cross Ref link Pubmed link , , , et al.
- 123 Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. J Infect Dis 1993;168:188–90. Cross Ref link Pubmed link , , , , .
- 124 Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice. Int J Lepr Other Mycobact Dis 1994;62:37–42. Pubmed link , , , , .
- 125 Minocycline‐induced hyperpigmentation in leprosy. Br J Dermatol 1996;134:784–7. Cross Ref link Pubmed link , , , et al.
- 126 Cunha G Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally. Lepr Rev 2012;83(3):241–4. Pubmed link .
- 127 Reversal reactions in leprosy and their management. Lepr Rev 1991;62:113–21. Pubmed link , .
- 128 Peripheral neuropathy in leprosy and its consequences. Lepr Rev 2000;71(Suppl.):S146–53. Pubmed link .
- 129 Nerve function impairment in leprosy. Design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (the Bangladesh Acute Nerve Damage Study). Lepr Rev 1999;70:140–59. Pubmed link , , , .
- 130 The pattern of leprosy‐related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome. Lepr Rev 2000;71:285–308. Pubmed link , , , et al.
- 131 Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation? Lepr Rev 1994;65:9–33. Pubmed link , .
- 132 The outpatient treatment of nerve damage in patients with borderline leprosy using a semi‐standardized steroid regimen. Lepr Rev 1985;56:127–34. Pubmed link , , .
- 133 Immunohistochemical analysis of cellular infiltrate and γ interferon, interleukin‐12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment. Infect Immun 2001;69:3413–17. Cross Ref link Pubmed link , , , et al.
- 134 A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous Normal saline and oral prednisolone in individuals with leprosy Type 1 reactions and /or nerve function impairment. PLOS Negl Trop Dis 2011;Apr 12;5(4):e1041. Cross Ref link Pubmed link , , .
- 135 Clinical response to cyclosporin A treatment in Ethiopian and Nepali patients with severe leprosy type 1 reactions (T1R). Trans R Soc Trop Med Hyg 2007;101:1004–12. Cross Ref link Pubmed link , , , et al.
- 136 The role of thalidomide in the management of erythema nodosum leprosum. Lep Rev 2007;78:197–215. , , .
- 137 Preventing Disability in Leprosy Patients. London: the Leprosy Mission International, 1986. .
- 138 Prevention of Disabilities in Patients with Leprosy: a Practical Guide. Geneva: World Health Organization, 1986.
- 139 The role of BCG in prevention of leprosy: a meta‐analysis. Lancet Infect Dis 2006;6:162–70. Cross Ref link Pubmed link , , , .
- 140 Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 1992;339:636–9. Cross Ref link Pubmed link , , , et al.
- 141 BCG vaccination protects against leprosy in Venezuela: a case‐control study. Int J Lepr Other Mycobact Dis 1993;61:185–91. Pubmed link , , , et al.
- 142 Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tberculosis in Malawi. Lancet 1996;348:17–24. Cross Ref link Pubmed link
- 143 Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet 1992;339:446–50. Cross Ref link Pubmed link , , , et al.
- 144 Anonymous. Bettering BCG. Lancet 1992;339:462–3. Cross Ref link Pubmed link
- 145 Hazards of targets to eliminate disease: lessons from the leprosy campaign. BMJ 2014;15–21. , , .